Browse by all authors Browse By Author Name - Cannell,+Paul

Browse Results (4 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Mollee, Peter, Tiley, Campbell, Cunningham, Ilona, Moore, John, Prince, H.Miles, Cannell, Paul, Gibbons, Steve, Tate, Jill, Paul, Sanjoy, Fan, Helen Mar and Gill, Devinder S. (2012) A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis. British Journal of Haematology, 157 6: 766-769. doi:10.1111/j.1365-2141.2012.09080.x 55   2 Cited 3 times in Scopus3 1
Mollee, Peter, Tiley, Campbell, Cunningham, Ilona, Moore, John, Prince, Miles, Cannell, Paul, Gibbons, Steve, Tate, Jill, Paul, Sanjoy and Gill, Devinder S. (2011). A Phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis. In: ASH Annual Meeting Abstracts 2011. 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH), San Diego, CA, United States, (1700-1700). Dec 10-13, 2011. 38   0
Snowden, John A., Passweg, Jakob, Moore, John J., Milliken, Sam, Cannell, Paul, Van Laar, Jacob, Verburg, Robert, Szer, Jeffrey, Taylor, Kerry, Joske, David, Rule, Simon, Bingham, Sarah J., Emery, Paul, Burt, Richard K., Lowenthal, Raymond M., Durez, Patrick., McKendry, Robert J., Pavletic, Steven Z., Espigado, Ildefonso, Jantunen, Esa, Kashyap, Ashwin, Rabusin, Marco, Brooks, Peter, Bredeson, Christopher and Tyndall, Alan (2004) Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: A report from the EBMT and ABMTR. Journal of Rheumatology, 31 3: 482-488. 261   82 Cited 114 times in Scopus114
Richardson, Paul G., Spencer, Andrew, Cannel, Paul, Harrison, Simon J., Catley, Laurence, Underhill, Craig, Zimmerman, Todd M., Hofmeister, Craig C., Jakubowiak, Andrzej J., Laubach, Jacob P., Palladino, Michael A., Longenecker, Angie M., Lay, Ana, Wear, Sandra, Lloyd, G. Kenneth, Hannah, Alison L., Reich, Steve, Spear, Matthew A. and Anderson, Kenneth C. (2011). Phase 1 Clinical Evaluation of Twice-Weekly Marizomib (NPI-0052), a Novel Proteasome Inhibitor, in Patients with Relapsed/Refractory Multiple Myeloma (MM). In: Blood. 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego Ca, (140-141). Dec 10-13, 2011. 69   0